It has been reported that XIST overexpression is highly correlated with poorer prognoses in patients with various cancers, including colon cancer [7], pancreatic cancer [8], and brain cancer [9]; however, the role of XIST in CRC remains poorly understood. Here, XIST is linked to familial pancreatic carcinoma.